从前列腺癌诊断到转移性或非转移性前列腺癌 (CRPC) 患者的疾病进展的比较:CaPA研究
Pedro Costa1, António Patrício2, João Vasco Barreira3
1Urology Department, Vila Nova de Gaia Hospital Center, Vila Nova de Gaia, Portugal.
Cancer medicine
|August 20, 2025
概括
转移性抵抗性前列腺癌 (mCRPC) 患者的进展速度比非转移性 (nmCRPC) 患者快. 在nmCRPC中,更好的初始预后因素和治疗反应可能解释了缓慢进展到割抵抗.
科学领域:
- 癌症学
- 尿道病学
- 癌症研究
背景情况:
- 前列腺癌 (PC) 进展为抵抗割的前列腺癌 (CRPC) 与生存率下降有关.
- 了解患者的特征和疾病管理对于推迟CRPC至关重要.
- 需要实际数据来比较CRPC患者的发展轨迹.
研究的目的:
- 从初始诊断到转移性CRPC (mCRPC) 与非转移性CRPC (nmCRPC) 阶段的PC患者的特征和比较.
- 在现实环境中确定影响PC到CRPC的因素.
主要方法:
- 在葡萄牙进行多中心,回顾性,非干预性研究.
- 包括121名被诊断为CRPC的成年患者 (转移或非转移).
- 在诊断时或CRPC诊断后12个月内收集的数据.
主要成果:
- 诊断时的中位数年龄相似 (69. 0mCRPC与70. 0nmCRPC).
- 在mCRPC和nmCRPC组之间,ECOG PS,格里森得分和AJCC阶段有显著差异.
- 在mCRPC诊断时mCRPC的PSA水平较高,而mCRPC的时间较短 (42. 0个月).
结论:
- 与mCRPC患者相比,nmCRPC患者的割耐药性进展时间明显较长.
- 在nmCRPC患者中,有利的初始预后因素和治疗反应可能有助于减缓疾病的进展.
- 这些发现突显了mCRPC和nmCRPC疾病进展途径的差异.
相关概念视频
02:07Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
01:21Cancer Survival Analysis
445
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
445
01:20Comparing the Survival Analysis of Two or More Groups
279
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
279